Journal of the Chemical Society, Dalton Transactions p. 3603 - 3608 (1996)
Update date:2022-08-03
Topics:
Fernandez, Eduardo J.
Gimeno, M. Concepcion
Jones, Peter G.
Laguna, Antonio
Laguna, Mariano
Olmos, Elena
Treatment of [M(CO)4{(Ph2PCH2)2CMe(CH 2PPh2)}] (M = Mo or W) with neutral or cationic gold-(I) or -(III) derivatives afforded bi- or tri-nuclear complexes containing the triphosphine (Ph2PCH2)3CMe (tdppme) acting as a μ-P,P′,P″ ligand, a co-ordination mode poorly represented thus far. The binuclear derivative [(OC)4Mo(tdppme)AuCl] further reacts with 1 equivalent of Tl(acac) (acac = acetylacetonate) to afford [(OC)4Mo(tdppme)Au(acac)]. This complex acts as a deprotonating agent in reactions with various starting materials containing phosphines such as (Ph2P)2CH2 or (Ph2P)3CH, leading to the formation of trinuclear methanide complexes. The crystal structure of [(OC)4Mo(tdppme)AuCl] has been established by X-ray crystallography.
View MoreContact:+33-5-34012600
Address:28 ZA des Pignès
Hubei Onward Bio-Development Co., Ltd.
Contact:+86-718-8417012
Address:No.517,Shizhou Avenue,Enshi City,Hubei Province,China,445002
Contact:+(852) 301-98033
Address:Flat C, 23/F, Lucky Plaza, 315-321 Lockhart Road, Wan Chai, Hong Kong
Contact:+86-731-84427351
Address:154 JIANXIANG SOUTH ROAD
Anhui Qingyun Pharmaceutical and Chemical Co.,Ltd
Contact:+86-551-63633067
Address:Shuangfeng Road Hefei Anhui
Doi:10.1016/0040-4039(96)01758-3
(1996)Doi:10.1039/c39800000980
(1980)Doi:10.1063/1.1671734
(1969)Doi:10.1002/ejoc.202000837
(2020)Doi:10.1016/j.tetlet.2011.11.051
(2012)Doi:10.1002/1521-3773(20011203)40:23<4441::AID-ANIE4441>3.0.CO;2-I
(2001)
